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Summary. Plasma arginine vasopressin concentrations were determined by 
radio-immunoassay in 112 adult epileptics who were taking carbamazepine, 
phenytoin, primidone, or sodium valproate in long-term onotherapy, and in 
19 controls. No significant difference was found between the groups, but some 
epileptics taking carbamazepine and primidone showed low values. Serum 
concentrations of carbamazepine did not correlate with the concentrations of 
plasma rginine vasopressin. In conclusion, there was no evidence of a stimu- 
lating effect of chronic carbamazepine medication or a special inhibiting 
effect of phenytoin on the release of vasopressin arginine from the posterior 
pituitary. 
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Zusammenfassung. Bei 112 unter Monotherapie mit Carbamazepin, Pheny- 
toin, Primidon oder Valproat stehenden erwachsenen Anfallskranken sowie 
bei 19 gleichaltrigen Kontrollpersonen wurden radioimmunologisch die 
Vasopressin-Plasma-Konzentrationen bestimmt. Es wurden keine signifikan- 
ten Unterschiede zwischen den Gruppen gefunden. Einige der mit Carbama- 
zepin und Primidon monotherapierten Epileptiker wiesen iedrige Vasopres- 
sin-Werte auf. Die Carbamazepin-Serumspiegel korrelierten icht mit den 
Vasopressin-Konzentrationen. Somit ergab sich weder ein Hinweis auf eine 
vermehrte Vasopressin-Ausschiittung ter Langzeittherapie mit Carbama- 
zepin noch eine besondere Hemmung der Ausschtittung durch Phenytoin. 
Different influences on diuresis have been reported for carbamazepine and 
phenytoin. While carbamazepine has been shown to have an antidiuretic effect 
[1, 4, 6, 7, 9,11,12], phenytoin can reverse carbamazepine-induced water intoxica- 
tion [10] and interferes (when given in high intravenous doses) with the release of 
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Fig. 1. Plasma arginine vasopressin concentrations in epileptics under long-term onotherapy 
with anticonvulsants (group 1, carbamazepine; group 2, phenytoin; group 3, primidone; group 
4, valproate sodium) and in controls 
arginine vasopressin [2]. It has been suggested that carbamazepine exerts its 
antidiuretic effect by stimulating the release of antidiuretic hormone from the 
posterior pituitary [1, 4, 9], but this could not be confirmed by others [3,11]. Thus, 
the effect of carbamazepine on plasma antidiuretic hormone concentration 
remains uncertain [5,13]. The aim of the present study was to investigate the 
influence of different anticonvulsants on the plasma arginine vasopressin 
concentrations in adult epileptic patients receiving long-term monotherapy with 
carbamazepine, phenytoin, primidone and valproate sodium. 
Patients and methods  
Plasma arginine vasopressin concentrations were determined using a sensitive and specific 
radio-immunoassay [8]. Measurements were carried out in the plasma of 112 adult epileptics 
aged 20-40 years, receiving anticonvulsant mo otherapy for at least 1 year, nd of 19 controls 
of the same age; 27 patients were taking carbamazepine (group 1), 29 phenytoin (group 2), 42 
primidone (group 3),and 14 sodium valproate (group 4). Levels of anticonvulsants in serum 
were determined by the enzyme multiplied immunoassay technique. Plasma sodium was 
determined by flame photometry. The significance of differences between the groups was 
assessed by analysis of variance, the correlation ofplasma arginine vasopressin concentrations 
and carbamazepine levels in serum was performed by linear regression analysis. 
Results  
The mean plasma arginine vasopressin concentration of the four groups of 
epileptics and of the controls did not differ significantly (mean-+- SD in group 1, 
1.96_0.97pmol/1; group 2, 2.22___0.71; group 3, 2.15___1.15; group 4, 2.51±1.28 
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and in controls 2.59___0.96). As shown in Fig. 1, vasopressin levels tended to be 
lower in some patients on carbamazepine and primidone. The serum concentra- 
tions of the anticonvulsants were within the therapeutic range in all epileptics 
(mean___ SD for carbamazepine 8.2_+ 2.4 I~g/ml, for phenytoin 8.6-+ 5.8 lag/ml, 
for primidone 12.0___5.2 lag/ml, and for sodium valproate 66.4_ 23.4 ~tg/ml). 
There was no significant correlation between the concentrations of plasma 
arginine vasopressin and carbamazepine (correlation coefficient r=-0.151, 
P> 0.05). No patient showed clinical signs of water intoxication; plasma sodium 
concentrations were within the normal range in all epileptics (mean_+SD in 
group 1, 140.3 ___2.8; group 2, 140.4_+1.2; group 3,140.4_+2.3; group 4, 140.2_+2.0 
mmol/1). 
Discussion 
The mechanisms of the antidiuretic effect of carbamazepine is not clear. Ashton 
et al. [1] and Smith et al. [9] demonstrated in their patients ahigh concentration of
arginine vasopressin the plasma ssociated with carbamazepine-induced water 
intoxication. On the other hand Heim et al. [3] and Stephens et al. [11] observed a 
decrease in the level of plasma arginine vasopressin after administration of 
carbamazepine in healthy volunteers. They concluded that carbamazepine 
increases the sensitivity of the kidney to antidiuretic hormone in combination 
with a resetting of osmoreceptors. Our results, showing normal to low values in 
patients on carbamazepine monotherapy, are in agreement with this assumption. 
Furthermore, there was no correlation between the concentrations of plasma 
arginine vasopressin and carbamazepine l vels in the serum. This finding 
confirms that there is no direct stimulating effect of carbamazepine, given in 
therapeutic doses, on the secretion of antidiuretic hormone in long-term treat- 
ment. It still remains possible that toxic levels of carbamazepine, which were 
absent in our series, could cause an increase in vasopressin production and 
consequently lead to water intoxication. Therefore, further studies on arginine 
vasopressin i  toxic patients would be of interest. 
In our patients treated with phenytoin, plasma rginine vasopressin was not 
reduced, in comparison with the other groups. Thus, chronic phenytoin adminis- 
tration seems not to have a direct effect on the posterior pituitary gland. This 
finding supports the hypothesis that the reversal by phenytoin of the antidiuretic 
effect of carbamazepine, s en in patients with combined therapy of both drugs, is 
caused only by a marked reduction of plasma carbamazepine concentrations 
during combined therapy with phenytoin [7]. 
Further studies of larger series of epileptics, with determinations ofplasma 
osmolality and sodium, will show whether there is a definite lowering of arginine 
vasopressin levels under carbamazepine and primidone therapy compared to 
other anticonvulsants. 
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